Fundraising Fox
/Companies
Sign in

Polku Therapeutics

5 employees on LinkedIn · 2 known investors

Find your way into Polku Therapeutics

Sign up to find every way you can get introduced to Polku Therapeutics

  • Your email: who you already know at Polku Therapeutics, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Polku Therapeutics team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.

BiotechDeep Tech

Founders & leadership

TTimo
TimoScientific Co-founderTimo is the scientific co-founder of Polku Therapeutics, a preclinical CNS company developing small-molecule therapies for tauopathies and related neurodegenerative diseases. He leads the NeuroCure lab at the University of Helsinki studying intracellular protein aggregation in Parkinson's and Alzheimer's disease, and has extensive experience in pharmacology and drug development spanning in vitro biochemical assays, cellular methods, and in vivo behavioral testing.
EErik
ErikScientific Co-founder
SSimon
SimonChief Executive Officer
SSebastian
SebastianChief Operating OfficerSebastian has spent a decade in life science venture roles spanning research and business development. He serves as Chief Operating Officer at Polku Therapeutics, where he oversees operations for a CNS drug discovery company developing small-molecule therapies for neurodegenerative diseases.

Investors · 2

InnovestorreportedFinland

How we know: funding news · press coverage · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Polku Therapeutics do?
Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.
Who founded Polku Therapeutics?
Polku Therapeutics was founded by Timo, Erik.
Who are Polku Therapeutics's investors?
Polku Therapeutics's investors include Torrey Pines Investment, Innovestor.